← All companies

AUPH

Aurinia Pharmaceuticals Inc.

AUPH Nasdaq Pharmaceutical Preparations EDGAR ↗

$14.57

-0.43 -2.87%

Key statistics

from XBRL data in SEC filings

Market cap

$1.87B

Revenue (TTM)

$298M

Net income (TTM)

$298M

EPS (TTM)

$2.17

P/E ratio

6.7

Dividend yield

—

Free cash flow

—

Cash

$40.7M

Total assets

$724M

Gross margin

—

52-week range

$10.34 – $19.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 4, 2026 8-K Completed an acquisition or disposition May 11, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 3, 2026 8-K Director or officer change Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release); Other events Jul 31, 2025 8-K Other events Jun 30, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results May 15, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change Nov 7, 2024 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Took on a direct financial obligation May 2, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 8-K Director or officer change Feb 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 15, 2024 8-K Results of operations (earnings release); Exit or disposal costs; Other events Feb 15, 2024 8-K Results of operations (earnings release) Jan 5, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Sep 21, 2023 8-K Director or officer change Aug 21, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023 8-K Director or officer change; Other events Jul 3, 2023 8-K Shareholder vote results May 17, 2023 10-Q Quarter ended 2023-03-31 May 4, 2023